Showing results (1081-1090 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|June 19, 2012
MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodulesHaggi MazehThe Oncologist|June 19, 2012
Fertility preservation in women undergoing treatment for breast cancer in the UK: a questionnaire studyJudy W King, Melanie C Davies, Nicola Roche, et al.The Oncologist|June 19, 2012
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinomaValérie Boige, David Malka, Abderrahmane Bourredjem, et al.The Oncologist|September 4, 2012
The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancerMarije E Hamaker, Alinda G Vos, Carolien H Smorenburg, et al.The Oncologist|July 19, 2012
Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?Laurence Albiges, Vincent Molinie, Bernard EscudierThe Oncologist|July 25, 2012
Management of unusual histological types of breast cancerKaren A Cadoo, Orla McArdle, Anne-Marie O'Shea, et al.The Oncologist|July 25, 2012
Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based studyZhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, et al.The Oncologist|February 7, 2015
TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancerKun Wang, Tiantian Liu, Cheng Liu, et al.The Oncologist|February 12, 2015
Phase I dose-escalation study of pilaralisib (SAR245408, XL147), a pan-class I PI3K inhibitor, in combination with erlotinib in patients with solid tumorsJean-Charles Soria, Patricia LoRusso, Ratislav Bahleda, et al.The Oncologist|February 13, 2015
Helical tomotherapy in head and neck cancer: a European single-center experienceDirk Van Gestel, Danielle Van den Weyngaert, Geert De Kerf, et al.Pageof 570